Physician profile
Rosaura E Baez
NPI 1750494555
$1,864.89
in general payments reported to CMS, 2019-2025
19 companies · $36.02 in 2025
The $36.02 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $791 · 2020: $362 · 2021: $258 · 2022: $88.06 · 2023: $144 · 2024: $185 · 2025: $36.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.72 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $870.58 | 2019-2024 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $271.35 | 2019-2020 | |
| Lilly USA, LLC | $186.82 | 2019-2025 | Mounjaro, Zepbound, Amyvid |
| Nevro Corp. | $107.24 | 2019 | |
| Glaxosmithkline, LLC. | $67.51 | 2023-2024 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $56.51 | 2022-2024 | |
| Gilead Sciences, INC. | $48.87 | 2021 | |
| Amarin Pharma, INC. | $45.50 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $28.48 | 2020 | |
| Abbvie INC. | $24.21 | 2021 | |
| Boston Scientific Corporation | $24.13 | 2019-2020 | |
| Dexcom, INC. | $23.93 | 2024 | Dexcom G6 Transmitter |
| Alfasigma USA, INC. | $23.24 | 2021 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Radius Health, INC. | $16.90 | 2023 | Tymlos |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $13.73 | 2023 | Veozah |
| Janssen Pharmaceuticals, INC | $13.38 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.08 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosaura Baez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.